secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2025-02-07T23:59:59+00:00
Accession:  0001104659-25-010580
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma CFO Mark Guerin resigns; Nora Brennan named Interim CFO
--------------------------------------------------------------------

- Mark Guerin resigned as CFO effective Feb 5, 2025; receives $250K in 9 monthly installments plus $150K lump sum.
- Guerin gets $75K RSUs vesting over 2 years, accelerated vesting of all outstanding awards, option exercise extended to Feb 2026.
- Nora Brennan appointed Interim CFO effective Feb 5; compensation $42K/month through July 5, 2025.
- Brennan previously CFO at Spectrum Pharmaceuticals and TELA Bio; led TELA Bio through IPO.
- If extended after July 5, Brennan eligible for $425K salary, 115K RSUs, and target bonus up to 50% of salary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925010580/0001104659-25-010580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925010580/tm255838d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-010580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer